HCV, HBV coinfection raises hepatocellular carcinoma risk

09/30/2011 | Medscape (free registration)

Patients with both hepatitis B and C are at higher risk of hepatocellular carcinoma than those with just one of the viruses but age and gender also are factors, Harvard University researchers reported in the Journal of Clinical Oncology. They said antiviral and interferon treatments may reduce the risk of HCC.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC